Analysis of measles virus binding sites of the CD46 gene in patients with subacute sclerosing panencephalitis

Journal of Infectious Diseases

Volumn 181, Issue 4, 2000, Pages 1447-1449

  Kusuhara, Koichi ^a   Sasaki, Yuka ^a   Nakao, Futoshi ^a   Ihara, Kenji ^a   Hattori, Hideji ^g   Yamashita, Sumimasa ^b   Nihei, Kenji ^c   Koide, Nobuo ^d   Aiba, Hideo ^e   Takeshita, Kenzo ^f   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

^c NATIONAL CHILDREN S HOSPITAL   (Japan)

^d National Hospital Organization Iwaki Hospital   (Japan)

^e SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

^f TOTTORI UNIVERSITY   (Japan)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BINDING SITE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS GENE; VIRUS REPLICATION;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD46; BINDING SITES; CHILD; CHILD, PRESCHOOL; EXONS; FEMALE; GENE FREQUENCY; HUMANS; MALE; MEASLES VIRUS; MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 0034023783     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315386     Document Type: Article

References (15)

1. 1. Kai C, Yamanouchi K, Sakata H, Miyashita N, Takahashi H, Kobune F. Nucleotide sequences of the M gene of prevailing wild measles viruses and a comparison with subacute sclerosing panencephalitis virus. Virus Genes 1996;12:85-7.
2. 2. Naniche D, Varior-Krishnan G, Cervoni F, et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993;67: 6025-32.
3. 3. Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993;75:295-305.
4. 4. Schneider-Schaulies J, Schnorr JJ, Brinckmann U, et al. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci USA 1995;92:3943-7.
5. 5. Ogata A, Czub S, Ogata S, et al. Absence of measles virus receptor (CD46) in lesions of subacute sclerosing panencephalitis brains. Acta Neuropathol (Berl) 1997;94:444-9.
6. 6. Lawrence DM, Vaughn MM, Belman AR, Cole JS, Rall GF. Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and central nervous system disease. J Virol 1999;73:1795-801.
7. 7. Gascon GG. Subacute sclerosing panencephalitis. Semin Pediatr Neurol 1996;3:260-9.
8. 8. Pollard AJ, Flanagan BF, Newton DJ, Johnson PM. A novel isoform of human membrane cofactor protein (CD46) mRNA generated by intron retention. Gene 1998;212:39-47.
9. 9. Karp CL. Measles: immunosuppression, interleukin-12, and complement receptors. Immunol Rev 1999;168:91-101.
10. 10. Buckland R, Wild TF. Is CD46 the cellular receptor for measles virus? Virus Res 1997;48:1-9.
11. 11. Risk JM, Flanagan BF, Johnson PM. Polymorphism of the human CD46 gene in normal individuals and in recurrent spontaneous abortion. Hum Immunol 1991;30:162-7.
12. 12. Wilton AN, Johnstone RW, McKenzie IFC, Purcell DFJ. Strong associations between RFLP and protein polymorphisms for CD46. Immunogenetics 1992;36:79-85.
13. 13. Buchholz CJ, Koller D, Devaux P, et al. Mapping of the primary binding site of measles virus to its receptor CD46. J Biol Chem 1997;272:22072-9.
14. 14. Markowitz LE, Preblud SR, Fine PE, Orenstein WA. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J 1990;9:101-10.
15. 15. Poland GA. Immunogenetic mechanisms of antibody response to measles vaccine: the role of the HLA genes. Vaccine 1999;17:1719-25.